Search Results 121-130 of 18896 for B cell lymphomas

  1. An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas - Mayo Clinic

    ... lymphomas with CD30 expression that have not responded to treatment or have come back. The subtypes we are studying are Diffuse Large B-Cell Lymphoma (DLBCL) ...

  2. CAR-T Cell Therapy Program - Frequently asked questions - Mayo Clinic

    Aggressive B-cell lymphoma not otherwise specified (NOS); Mantle cell lymphoma; Follicular lymphoma; Multiple myeloma. How do I know if I'm eligible for CAR-T ...

  3. Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia (CLOVER-WaM) - Mayo Clinic

    uptake by FDG-PET scan may be allowed with prior approval of Sponsor. Patients with Diffuse Large B-Cell Lymphoma - Relapsed or refractory to combination ...

  4. Clinical trials - Oncology (Medical)

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  5. Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    ... B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma. Print ... B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.

  6. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma.

  7. Hodgkin lymphoma (Hodgkin disease) - Doctors and departments - Mayo Clinic

    Learn how this cancer differs from other lymphomas. Find out about risk ... ffuse large b-cell lymphoma, Mantle cell lymphoma, Follicular lymphoma. Show ...

  8. Hodgkin Lymphoma (Hodgkin Disease) Clinical Trials - Mayo Clinic Research

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  9. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    ... B-Cell Lymphoma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

  10. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

    The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large B- ...